Chapters

Transcript

Video

Wenxin (Vincent) Xu, MD presents a potential biomarker (KIM-1)

Evaluation of circulating kidney injury marker-1 (KIM-1) as a prognostic and predictive biomarker in advanced renal cell carcinoma (aRCC): Post-hoc analysis of CheckMate 214.

Related Presenters

Wenxin Xu, MD.

Wenxin Xu, MD

Medical Oncology

View full Profile

ADVERTISEMENT

Related Videos